Sign in

CIK 0000034956 · Non-accelerated filer<br>Smaller reporting company

TENAX THERAPEUTICS, INC.

Sign in to watch
Ticker
TENX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
262593535
Phone
919-855-2100
Business address
101 GLEN LENNOX DRIVE, SUITE 300, CHAPEL HILL, NC, 27517
Former names
OXYGEN BIOTHERAPEUTICS, INC., SYNTHETIC BLOOD INTERNATIONAL INC
  1. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  2. 10-Q Report Quarterly Report
  3. 8-K Event Results of operations
  4. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  5. 4 Open-market buy 10% owner bought 922,849 shares at an average $1.59 ($1,463,426)
  6. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  7. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  8. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  9. 8-K Event Other events
  10. 4 Open-market buy Director bought 53,000 shares at $1.92 ($101,760)
  11. 4 Open-market buy CEO bought 10,850 shares at an average $1.85 ($20,087)
  12. 4 Open-market buy Chief Financial Officer bought 5,675 shares at $1.94 ($10,981)
  13. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  14. 8-K Event Regulation FD disclosure
  15. 4 Open-market buy 10% owner bought 900,000 shares at $1.78 ($1,604,160)
  16. SCHEDULE 13G Stake Statement of Beneficial Ownership
  17. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  18. 4 Open-market buy 10% owner bought 770,333 shares at an average $1.79 ($1,381,750)
  19. SCHEDULE 13G Stake Statement of Beneficial Ownership
  20. SCHEDULE 13G Stake Statement of Beneficial Ownership

Page 1 of 50 · 996 filings